HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.59
+0.14 (1.04%)
At close: Apr 28, 2026, 4:00 PM EDT
13.59
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HUTCHMED (China) stock has a target of 13.75, which predicts an increase of 1.18% from the current stock price of 13.59.
Analyst Consensus: Sell
* Price targets were last updated on Sep 22, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for HUTCHMED (China) is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $18 → $14 | Hold → Sell | Downgrades | $18 → $14 | +1.18% | Sep 22, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +39.81% | Aug 1, 2024 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +62.62% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +25.09% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +267.92% | Sep 5, 2023 |
Financial Forecast
Revenue This Year
661.53M
from 548.51M
Increased by 20.60%
Revenue Next Year
764.89M
from 661.53M
Increased by 15.62%
EPS This Year
0.07
from 0.52
Decreased by -87.01%
EPS Next Year
0.11
from 0.07
Increased by 64.73%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 797.0M | 1.1B | |||
| Avg | 661.5M | 764.9M | |||
| Low | 585.1M | 644.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 45.3% | 63.3% | |||
| Avg | 20.6% | 15.6% | |||
| Low | 6.7% | -2.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.26 | 0.28 | ||
| Avg | 0.07 | 0.11 | ||
| Low | 0.01 | 0.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -49.5% | 319.7% | ||
| Avg | -87.0% | 64.7% | ||
| Low | -98.1% | -42.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.